OrthoPediatrics (NASDAQ:KIDS) Shares Gap Up - Still a Buy?

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $24.86, but opened at $25.51. OrthoPediatrics shares last traded at $25.28, with a volume of 7,053 shares.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Truist Financial cut their price target on OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a report on Wednesday, December 18th. Needham & Company LLC reiterated a "buy" rating and set a $42.00 target price on shares of OrthoPediatrics in a research report on Wednesday, March 5th. Finally, Stifel Nicolaus lowered their price target on shares of OrthoPediatrics from $40.00 to $32.00 and set a "buy" rating for the company in a report on Wednesday, March 5th.

OrthoPediatrics Stock Down 0.0 %

The firm has a market capitalization of $600.86 million, a price-to-earnings ratio of -20.11 and a beta of 1.22. The company has a debt-to-equity ratio of 0.19, a quick ratio of 3.68 and a current ratio of 7.17. The business's 50-day moving average is $24.75 and its two-hundred day moving average is $25.28.

OrthoPediatrics (NASDAQ:KIDS - Get Free Report) last posted its quarterly earnings data on Tuesday, March 4th. The company reported ($0.29) EPS for the quarter, beating the consensus estimate of ($0.33) by $0.04. The business had revenue of $52.67 million for the quarter, compared to analysts' expectations of $51.16 million. OrthoPediatrics had a negative net margin of 15.00% and a negative return on equity of 5.78%. During the same period in the previous year, the firm posted ($0.23) EPS. On average, equities analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current year.

Remove Ads

Insider Buying and Selling

In related news, CEO David R. Bailey sold 6,620 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total value of $164,573.20. Following the sale, the chief executive officer now owns 319,155 shares in the company, valued at approximately $7,934,193.30. This represents a 2.03 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Gregory A. Odle sold 5,359 shares of OrthoPediatrics stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $24.86, for a total transaction of $133,224.74. Following the sale, the insider now directly owns 148,788 shares of the company's stock, valued at $3,698,869.68. The trade was a 3.48 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,732 shares of company stock worth $589,978. Corporate insiders own 31.80% of the company's stock.

Institutional Investors Weigh In On OrthoPediatrics

Hedge funds have recently bought and sold shares of the stock. Millennium Management LLC acquired a new stake in shares of OrthoPediatrics during the fourth quarter worth $9,798,000. Point72 Asset Management L.P. bought a new stake in OrthoPediatrics during the fourth quarter worth about $7,450,000. Wasatch Advisors LP increased its holdings in OrthoPediatrics by 47.2% in the 4th quarter. Wasatch Advisors LP now owns 696,318 shares of the company's stock valued at $16,141,000 after buying an additional 223,217 shares during the period. Wellington Management Group LLP raised its position in shares of OrthoPediatrics by 20.2% in the 4th quarter. Wellington Management Group LLP now owns 1,061,299 shares of the company's stock valued at $24,601,000 after buying an additional 178,078 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of OrthoPediatrics by 29.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 671,968 shares of the company's stock worth $15,576,000 after acquiring an additional 152,681 shares in the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.